Influence of haemodialysis on high-sensitivity C-reactive protein, lipoprotein(a), apolipoproteins A and B

被引：2
作者：
Lippi, Giuseppe
Tessitore, Nicola
Salvagno, Gian Luca
Bedogna, Valeria
Bassi, Antonella
Montagnana, Martina
Lupo, Antonio
Guidi, Gian Cesare
机构：
[1] Univ Verona, Dipartimento Sci Morfol Biomed, Sezione Chim Clin, I-37121 Verona, Italy
[2] Univ Verona, Dipartimento Sci Biomed & Chirug, Sez Nefrol, I-37100 Verona, Italy
来源：
CLINICAL BIOCHEMISTRY | 2007年 / 40卷 / 16-17期
关键词：
high-sensitivity C-reactive protein; chronic renal failure; haemodialysis; apolipoprotein; lipoprotein(a);
D O I：
10.1016/j.clinbiochem.2007.07.007
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Objectives: There is debate on the influence of haemodialysis (HD) on lipoprotein(a). Design and methods: Lp(a), apo A, apo B and high-sensitivity C-reactive protein (hs-CRP) were measured in 46 patients pre- and post-HD. Results: The median Lp(a) concentration significantly decreased post-HD (106 vs. 145 mg/L, p<0.001). No significant variations were observed for apo A, apo B and hs-CRP. Comparable results were observed with high- and low-flux membranes. Conclusion: HD is effective in lowering Lp(a). (C) 2007 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：1336 / 1338
页数：3
相关论文
共 10 条
[1]   Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: The CHOICE Study [J].
Astor, BC ;
Eustace, JA ;
Klag, MJ ;
Powe, NR ;
Longenecker, JC ;
Fink, NE ;
Marcovina, SM ;
Coresh, J .
KIDNEY INTERNATIONAL, 2002, 61 (03) :1115-1123
[2]  
Díaz-Peromingo JA, 2004, ACTA MED AUST, V31, P73
[3]  
Diop ME, 2000, CLIN NEPHROL, V54, P210
[4]   Randomized trial of high-flux vs low-flux haemodialysis:: effects on homocysteine and lipids [J].
House, AA ;
Wells, GA ;
Donnelly, JG ;
Nadler, SP ;
Hébert, PC .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1029-1034
[5]   Dyslipidemia in chronic kidney disease: Causes and consequences [J].
Kaysen, G. A. .
KIDNEY INTERNATIONAL, 2006, 70 :S55-S58
[6]   Biochemical risk factors and patient's outcome: the case of lipoprotein(a) [J].
Lippi, G ;
Guidi, G .
CLINICA CHIMICA ACTA, 1999, 280 (1-2) :59-71
[7]   High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients [J].
Longenecker, JC ;
Klag, MJ ;
Marcovina, SM ;
Liu, YM ;
Jaar, BG ;
Powe, NR ;
Fink, NE ;
Levey, AS ;
Coresh, J .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06) :1794-1802
[8]   Dominant negative effect of TGF-β1 and TNF-α on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures [J].
Ramharack, R ;
Barkalow, D ;
Spahr, MA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (06) :984-990
[9]  
SCHUMACHER M, 1994, EUR J CLIN CHEM CLIN, V32, P123
[10]   Cytokine release and serum lipoprotein (a) alterations during hemodialysis [J].
Tzanatos, HA ;
Agroyannis, B ;
Chondros, C ;
Kapetanaki, A ;
Fourtounas, C ;
Soubassi, L ;
Kopelias, I .
ARTIFICIAL ORGANS, 2000, 24 (05) :329-333
1